newsfilter
← Latest News
Business Wire·

Accelerator Life Science Partners' Portfolio Company Lodo Therapeutics Acquired by Zymergen Inc.

ZY

Accelerator Life Science Partners ("ALSP"), a leading early-stage life science accelerator and investment firm, today announced that its portfolio company, Lodo Therapeutics Corporation ("Lodo" or the "Company"), has been acquired by Zymergen Inc. (NASD